Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species
- PMID: 2989912
Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species
Abstract
Three hundred and twenty-seven animals comprised of deer, mouflon sheep and bighorn sheep were vaccinated with an experimental quadrivalent, modified-live, bluetongue virus (BTV) vaccine. No untoward effects due to the vaccine were noted nor were abortions observed in vaccinated pregnant mouflon sheep. Precipitating antibodies to BTV and epizootic hemorrhagic disease (EHD) virus were identified in the serum of several animals prior to vaccination. Virus neutralizing antibodies to 3 of the 5 serotypes of BTV which exist in the US were identified in the serum of 2 peninsular bighorn sheep.
Similar articles
-
Potency and efficacy of inactivated bluetongue virus vaccines.Prog Clin Biol Res. 1985;178:649-52. Prog Clin Biol Res. 1985. PMID: 2989914
-
Epidemiology of two orbiviruses in California's native wild ruminants: preliminary report.Prog Clin Biol Res. 1985;178:53-65. Prog Clin Biol Res. 1985. PMID: 2989899
-
Bluetongue and epizootic hemorrhagic disease viruses: their relationship to wildlife species.Adv Vet Sci Comp Med. 1978;22:111-32. Adv Vet Sci Comp Med. 1978. PMID: 216247 No abstract available.
-
Vaccines for Prevention of Bluetongue and Epizootic Hemorrhagic Disease in Livestock: A North American Perspective.Vector Borne Zoonotic Dis. 2015 Jun;15(6):385-96. doi: 10.1089/vbz.2014.1698. Vector Borne Zoonotic Dis. 2015. PMID: 26086559 Review.
-
Bluetongue vaccines: the past, present and future.Expert Rev Vaccines. 2009 Feb;8(2):191-204. doi: 10.1586/14760584.8.2.191. Expert Rev Vaccines. 2009. PMID: 19196199 Review.